{{Rsnum
|rsid=3745009
|Gene=SLC14A2
|Chromosome=18
|position=45682394
|Orientation=minus
|GMAF=0.4027
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC14A2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 29.2 | 50.4 | 20.4
| HCB | 39.7 | 45.6 | 14.7
| JPT | 38.1 | 46.9 | 15.0
| YRI | 41.1 | 45.2 | 13.7
| ASW | 33.3 | 50.9 | 15.8
| CHB | 39.7 | 45.6 | 14.7
| CHD | 32.1 | 50.5 | 17.4
| GIH | 36.6 | 36.6 | 26.7
| LWK | 33.0 | 54.1 | 12.8
| MEX | 37.9 | 56.9 | 5.2
| MKK | 19.2 | 48.1 | 32.7
| TSI | 26.5 | 51.0 | 22.5
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs3745009
|Name_s=SLC14A2:Ala357Thr
|Gene_s=SLC14A2
|Feature=
|Evidence=PubMed ID:17344938
|Annotation=In a Chinese population, this SNP was significantly associated with blood pressure response to nifedipine treatment.
|Drugs=nifedipine
|Drug Classes=
|Diseases=Hypertension
|Curation Level=Curated
|PharmGKB Accession ID=PA162316709
}}

{{PMID Auto
|PMID=16642433
|Title=Polymorphism in maternal LRP8 gene is associated with fetal growth.
|OA=1
}}

{{GET Evidence
|gene=SLC14A2
|aa_change=Ala880Thr
|aa_change_short=A880T
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3745009
|overall_frequency_n=4621
|overall_frequency_d=10758
|overall_frequency=0.429541
|n_genomes=34
|n_genomes_annotated=0
|n_haplomes=40
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.001
|nblosum100=1
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}